These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37593252)

  • 1. Aerosolized Plus Intravenous Polymyxin B Versus Colistin in the Treatment of Pandrug-Resistant Klebsiella Pneumonia-mediated Ventilator-Associated Pneumonia: A Retrospective Cohort Study in Bangladesh.
    Hasan MJ; Sumi CD; Huq SMR; Anam AM; Rabbani R
    J Crit Care Med (Targu Mures); 2023 Apr; 9(2):106-115. PubMed ID: 37593252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case-control study.
    Liu J; Shao M; Xu Q; Liu F; Pan X; Wu J; Xiong L; Wu Y; Tian M; Yao J; Huang S; Zhang L; Chen Y; Zhang S; Wen Z; Du H; TaoWang ; Liu Y; Li W; Xu Y; Teboul JL; Chen D
    Ann Intensive Care; 2022 Aug; 12(1):72. PubMed ID: 35934730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B Plus Aerosolized Colistin vs Polymyxin B Alone in Hospital-acquired Pneumonia ("AEROCOL" Study): A Feasibility Study.
    Ghosh S
    Indian J Crit Care Med; 2024 Aug; 28(8):792-795. PubMed ID: 39239172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Susceptibility of MDR-
    Hasan MJ; Rabbani R; Anam AM; Santini A; Huq SMR
    J Crit Care Med (Targu Mures); 2021 Jan; 7(1):28-36. PubMed ID: 34722901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection.
    Maan L; Anand N; Yadav G; Mishra M; Gupta MK
    Cureus; 2023 Nov; 15(11):e49314. PubMed ID: 38143689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.
    Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G
    Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae.
    Abdelsalam MFA; Abdalla MS; El-Abhar HSE
    J Glob Antimicrob Resist; 2018 Dec; 15():127-135. PubMed ID: 30010061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates.
    Hussain K; Salat MS; Ambreen G; Mughal A; Idrees S; Sohail M; Iqbal J
    Expert Opin Drug Saf; 2020 Dec; 19(12):1641-1649. PubMed ID: 32892635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa.
    Mentzelopoulos SD; Pratikaki M; Platsouka E; Kraniotaki H; Zervakis D; Koutsoukou A; Nanas S; Paniara O; Roussos C; Giamarellos-Bourboulis E; Routsi C; Zakynthinos SG
    Intensive Care Med; 2007 Sep; 33(9):1524-32. PubMed ID: 17549457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study.
    Wu Z; Zhang S; Cao Y; Wang Q; Sun K; Zheng X
    Front Pharmacol; 2023; 14():1209063. PubMed ID: 37663252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study on intravenous combined with aerosol inhalation of polymyxin B for the treatment of pneumonia caused by multidrug-resistant Gram-negative bacteria].
    Zhou L; Li C; Weng Q; Wu J; Luo H; Xue Z; Xiao Y; Chen C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):416-420. PubMed ID: 34053483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.
    Abdellatif S; Trifi A; Daly F; Mahjoub K; Nasri R; Ben Lakhal S
    Ann Intensive Care; 2016 Dec; 6(1):26. PubMed ID: 27033711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized antibiotics for ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis.
    Xu F; He LL; Che LQ; Li W; Ying SM; Chen ZH; Shen HH
    Crit Care; 2018 Nov; 22(1):301. PubMed ID: 30442203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME
    Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics for ventilator-associated pneumonia.
    Arthur LE; Kizor RS; Selim AG; van Driel ML; Seoane L
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004267. PubMed ID: 27763732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.